The coronavirus has sufficiently disrupted life that it has our closest attention. And the private sector’s response — initiative, innovation and intrepidity — is inspirational.
Private-sector medical research-and-development innovators, such as biopharmaceutical companies and clinical labs, are working nonstop to discover diagnostics, therapeutics, vaccines and cures.
Medical device companies are making medical products of all sorts that are running in short supply and creating new devices for this unique situation.
Healthcare providers — hospitals, clinics, doctors, nurses — are screening and treating people potentially or actually infected with the virus.
